Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection

Supplemental material

  • Supplemental file 1 -

    Tables S1 (Determination of flavivirus infection status of late-convalescent-phase serum specimens), S2 (Determination of flavivirus infection status of early-convalescent-phase serum specimens from Nicaragua), S3 (Determination of flavivirus infection status of early-convalescent-phase serum specimens from Sri Lanka), S4 (Determination of flavivirus infection status of early-convalescent-phase serum specimens from Colombia), S5 (Characteristics of Z-EDIIIK394 reactivity with early-convalescent-phase sera), and S6 (Determination of flavivirus infection status of longitudinal specimens from Nicaraguan patients who had been infected with DENV)

    PDF, 82K

  • Supplemental file 2 -

    Fig. S1 (Effect of serum dilution on the specificity of Z-EDIII reactivity with early-convalescent-phase sera from patients infected with ZIKV, and/or DENV)

    PDF, 48K